{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:55:19Z","timestamp":1778219719430,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5U01HG007480-03"],"award-info":[{"award-number":["5U01HG007480-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004421","name":"World Bank Group","doi-asserted-by":"publisher","award":["ACE019"],"award-info":[{"award-number":["ACE019"]}],"id":[{"id":"10.13039\/100004421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In 2005, the Nigerian Federal Ministry of Health revised the treatment policy for uncomplicated malaria with the introduction of artemisinin-based combination therapies (ACTs). This policy change discouraged the use of Sulphadoxine-pyrimethamine (SP) as the second-line treatment of uncomplicated falciparum malaria. However, SP is used as an intermittent preventive treatment of malaria in pregnancy (IPTp) and seasonal malaria chemoprevention (SMC) in children aged 3\u201359\u00a0months. There have been increasing reports of SP resistance especially in the non-pregnant population in Nigeria, thus, the need to continually monitor the efficacy of SP as IPTp and SMC by estimating polymorphisms in dihydropteroate synthetase (<jats:italic>dhps<\/jats:italic>) and dihydrofolate reductase (<jats:italic>dhfr<\/jats:italic>) genes associated with SP resistance. The high resolution-melting (HRM) assay was used to investigate polymorphisms in codons 51, 59, 108 and 164 of the <jats:italic>dhfr<\/jats:italic> gene and codons 437, 540, 581 and 613 of the <jats:italic>dhps<\/jats:italic> gene. DNA was extracted from 271 dried bloodspot filter paper samples obtained from children (&lt;\u20095\u00a0years old) with uncomplicated malaria. The <jats:italic>dhfr<\/jats:italic> triple mutant I<jats:sub>51<\/jats:sub>R<jats:sub>59<\/jats:sub>N<jats:sub>108<\/jats:sub>, <jats:italic>dhps<\/jats:italic> double mutant G<jats:sub>437<\/jats:sub>G<jats:sub>581<\/jats:sub> and quadruple <jats:italic>dhfr<\/jats:italic> I<jats:sub>51<\/jats:sub>R<jats:sub>59<\/jats:sub>N<jats:sub>108<\/jats:sub>\u2009+\u2009<jats:italic>dhps<\/jats:italic> G<jats:sub>437<\/jats:sub> mutant haplotypes were observed in 80.8%, 13.7% and 52.8% parasites, respectively. Although the quintuple <jats:italic>dhfr<\/jats:italic> I<jats:sub>51<\/jats:sub>R<jats:sub>59<\/jats:sub>N<jats:sub>108<\/jats:sub>\u2009+\u2009<jats:italic>dhps<\/jats:italic> G<jats:sub>437<\/jats:sub>E<jats:sub>540<\/jats:sub> and sextuple <jats:italic>dhfr<\/jats:italic> I<jats:sub>51<\/jats:sub>R<jats:sub>59<\/jats:sub>N<jats:sub>108<\/jats:sub>\u2009+\u2009<jats:italic>dhps<\/jats:italic> G<jats:sub>437<\/jats:sub>E<jats:sub>540<\/jats:sub>G<jats:sub>581<\/jats:sub> mutant haplotypes linked with <jats:italic>in-vivo<\/jats:italic> and <jats:italic>in-vitro<\/jats:italic> SP resistance were not detected, constant surveillance of these haplotypes should be done in the country to detect any change in prevalence.<\/jats:p>","DOI":"10.1038\/s41598-020-80017-6","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T18:36:08Z","timestamp":1610476568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique"],"prefix":"10.1038","volume":"11","author":[{"given":"Adeyemi T.","family":"Kayode","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fehintola V.","family":"Ajogbasile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazeem","family":"Akano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica N.","family":"Uwanibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Oluniyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philomena J.","family":"Eromon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onikepe A.","family":"Folarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akintunde","family":"Sowunmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dyann F.","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian T.","family":"Happi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"80017_CR1","volume-title":"National Antimalarial Treatment Guidelines","author":"Federal Ministry of Health","year":"2005","unstructured":"Federal Ministry of Health. National Antimalarial Treatment Guidelines (Federal Ministry of Health, Abuja, 2005)."},{"issue":"2","key":"80017_CR2","first-page":"003756","volume":"2012","author":"M Meremikwu","year":"2012","unstructured":"Meremikwu, M., Donegan, S., Sinclair, D., Esu, E. & Oringanje, C. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst. Rev. 2012(2), 003756\u2013003756 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"80017_CR3","volume-title":"World Malaria Report, 2013","author":"WHO","year":"2013","unstructured":"WHO. World Malaria Report, 2013 (WHO, Geneva, 2013)."},{"key":"80017_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12936-017-1811-2","volume":"16","author":"D Ndiaye","year":"2017","unstructured":"Ndiaye, D. et al. High-resolution melting: A useful field-deployable method to measure dhfr and dhps drug resistance in both highly and lowly endemic plasmodium populations. Malar. J. 16, 153 (2017).","journal-title":"Malar. J."},{"issue":"3","key":"80017_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.actatropica.2005.06.015","volume":"95","author":"C Happi","year":"2005","unstructured":"Happi, C. et al. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine\u2013pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Trop. 95(3), 183\u2013193 (2005).","journal-title":"Acta Trop."},{"key":"80017_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0166-6851(97)00114-X","volume":"89","author":"P Wang","year":"1997","unstructured":"Wang, P. et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol. Biochem. Parasitol. 89, 161\u2013177 (1997).","journal-title":"Mol. Biochem. Parasitol."},{"issue":"3","key":"80017_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/civ881","volume":"62","author":"M Desai","year":"2016","unstructured":"Desai, M. et al. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin. Infect. Dis. 62(3), 323\u2013333 (2016).","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"80017_CR8","doi-asserted-by":"publisher","first-page":"e13438","DOI":"10.1371\/journal.pone.0013438","volume":"5","author":"J Nankabirwa","year":"2010","unstructured":"Nankabirwa, J. et al. Efficacy, safety, and tolerability of three regimens for prevention of malaria: A randomized, placebo-controlled trial in Ugandan Schoolchildren. PLoS ONE 5(10), e13438 (2010).","journal-title":"PLoS ONE"},{"issue":"2","key":"80017_CR9","doi-asserted-by":"publisher","first-page":"e4569","DOI":"10.1371\/journal.pone.0004569","volume":"4","author":"S Gesase","year":"2009","unstructured":"Gesase, S. et al. High resistance of Plasmodium falciparum to sulphadoxine\/pyrimethamine in Northern Tanzania and the emergence of dhps resistance mutation at codon 581. PLoS ONE 4(2), e4569 (2009).","journal-title":"PLoS ONE"},{"issue":"1","key":"80017_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1475-2875-11-82","volume":"11","author":"CA Onoka","year":"2012","unstructured":"Onoka, C. A., Hanson, K. & Onwujekwe, O. E. Low coverage of intermittent preventive treatment for malaria in pregnancy in Nigeria: Demand-side influences. Malar. J. 11(1), 82. https:\/\/doi.org\/10.1186\/1475-2875-11-82 (2012).","journal-title":"Malar. J."},{"key":"80017_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ijpddr.2016.08.004","volume":"6","author":"M Oguike","year":"2016","unstructured":"Oguike, M. et al. Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V. Int. J. Parasitol. Drugs Drug Resist. 6, 220\u2013229 (2016).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"1","key":"80017_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12936-018-2394-2","volume":"17","author":"E Esu","year":"2018","unstructured":"Esu, E. et al. Intermittent screening and treatment with artemether\u2013lumefantrine versus intermittent preventive treatment with sulfadoxine\u2013pyrimethamine for malaria in pregnancy: A facility-based, open-label, non-inferiority trial in Nigeria. Malar. J. 17(1), 251 (2018).","journal-title":"Malar. J."},{"issue":"1","key":"80017_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40249-020-00712-4","volume":"9","author":"H Quan","year":"2020","unstructured":"Quan, H. High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria. Infect. Dis. Poverty 9(1), 91 (2020).","journal-title":"Infect. Dis. Poverty"},{"issue":"9","key":"80017_CR14","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1093\/jac\/dkv160","volume":"70","author":"P Chauvin","year":"2015","unstructured":"Chauvin, P. et al. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine\/pyrimethamine in pregnant women in Yaound\u00e9, Cameroon: Emergence of highly resistant dhfr\/dhfr alleles. Antimicrob. Chemother. 70(9), 2566\u20132571 (2015).","journal-title":"Antimicrob. Chemother."},{"key":"80017_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/aasopenres.12825.1","volume":"1","author":"J Abugri","year":"2018","unstructured":"Abugri, J. et al. Prevalence of chloroquine and antifolate drug resistance alleles in Plasmodium falciparum clinical isolates from three areas in Ghana. AAS Open Res. 1, 1 (2018).","journal-title":"AAS Open Res."},{"issue":"7","key":"80017_CR16","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1128\/AAC.04961-14","volume":"59","author":"N Lucchi","year":"2015","unstructured":"Lucchi, N. et al. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya. Antimicrob. Agents Chemother. 59(7), 3995\u20134002 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"80017_CR17","doi-asserted-by":"publisher","first-page":"e0137440","DOI":"10.1371\/journal.pone.0137440","volume":"10","author":"M Tahita","year":"2015","unstructured":"Tahita, M. et al. Prevalence of the dhfr and dhps mutations among pregnant women in rural burkina faso five years after the introduction of intermittent preventive treatment with sulfadoxine-pyrimethamine. PLoS ONE 10(9), e0137440\u2013e0137440 (2015).","journal-title":"PLoS ONE"},{"issue":"5","key":"80017_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1159\/000430987","volume":"24","author":"B Iwalokun","year":"2015","unstructured":"Iwalokun, B., Iwalokun, S., Adebodun, V. & Balogun, M. Carriage of mutant dihydrofolate reductase and dihydropteroate synthase genes among Plasmodium falciparum isolates recovered from pregnant women with asymptomatic infection in Lagos, Nigeria. Med. Princ. Pract. 24(5), 436\u2013443 (2015).","journal-title":"Med. Princ. Pract."},{"issue":"5","key":"80017_CR19","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.4314\/ijbcs.v8i5.1","volume":"8","author":"F Ikpa","year":"2015","unstructured":"Ikpa, F., Shaa, K. & Auta, K. Molecular markers of sulfadoxine-pyrimethamine resistant malaria prior to intermittent preventive treatment among pregnancies in Makurdi, Nigeria. Int. J. Bio. Chem. Sci. 8(5), 1961\u20131968 (2015).","journal-title":"Int. J. Bio. Chem. Sci."},{"key":"80017_CR20","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1128\/AAC.47.4.1347-1354.2003","volume":"1","author":"R Pearce","year":"2003","unstructured":"Pearce, R., Drakeley, C., Chandramohan, D., Mosha, F. & Roper, C. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of Northern Tanzania. Antimicrob. Chemother 1, 1347\u20131354 (2003).","journal-title":"Antimicrob. Chemother"},{"key":"80017_CR21","unstructured":"Ajogbasile, F. et al. Microsatellite loci analysis reveals high intra-population diversity and low population differentiation in parasite from nine Nigeria States 10 years post adoption of ACTs. (2020)."},{"issue":"10","key":"80017_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","volume":"29","author":"I Naidoo","year":"2013","unstructured":"Naidoo, I. & Roper, C. Mapping partially resistant, fully resistant, and super resistant malaria. Trends Parasitol. 29(10), 505\u2013515 (2013).","journal-title":"Trends Parasitol."},{"key":"80017_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0001-706X(02)00264-4","volume":"85","author":"B Bwijo","year":"2003","unstructured":"Bwijo, B. et al. High prevalence of quintuple mutant dhps\/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop. 85, 363\u2013373 (2003).","journal-title":"Acta Trop."},{"key":"80017_CR24","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.1098876","volume":"305","author":"C Roper","year":"2004","unstructured":"Roper, C., Pearce, R., Nair, S., Nosten, F. & Anderson, T. Intercontinental spread of pyrimethamine-resistant malaria. Science 305, 1124 (2004).","journal-title":"Science"},{"key":"80017_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijpddr.2013.07.001","volume":"3","author":"D Ndiaye","year":"2013","unstructured":"Ndiaye, D. et al. Polymorphism in dhfr\/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal. Int. J. Parasitol Drugs Drug resist. 3, 135\u2013142 (2013).","journal-title":"Int. J. Parasitol Drugs Drug resist."},{"issue":"3","key":"80017_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4269\/ajtmh.18-0115","volume":"99","author":"J Ebenebe","year":"2018","unstructured":"Ebenebe, J. et al. Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old nigerian children ten years following adoption as first-line antimalarials. Am. J. Trop. Med. Hyg. 99(3), 649\u2013664 (2018).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"80017_CR27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12936-018-2623-8","volume":"17","author":"B Bankole","year":"2018","unstructured":"Bankole, B. et al. Characterization of Plasmodium falciparum structure in Nigeria with malaria SNPs barcode. Malar. J. 17(1), 472 (2018).","journal-title":"Malar. J."},{"issue":"1","key":"80017_CR28","first-page":"85","volume":"73","author":"S Viriyakosol","year":"1995","unstructured":"Viriyakosol, S. et al. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull. World Health Organ. 73(1), 85\u201395 (1995).","journal-title":"Bull. World Health Organ."},{"issue":"3","key":"80017_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.4314\/ahs.v16i3.10","volume":"16","author":"O Kolawole","year":"2016","unstructured":"Kolawole, O., Mokuolu, O., Olukosi, A. & Oloyede, T. Population genomics diversity of Plasmodium falciparum in malaria patients attending Okelele Health Centre, Okelele, Ilorin, Kwara State, Nigeria. Afr. Health Sci. 16(3), 704\u2013711 (2016).","journal-title":"Afr. Health Sci."},{"issue":"6","key":"80017_CR30","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1128\/AAC.05737-11","volume":"56","author":"R Daniels","year":"2012","unstructured":"Daniels, R. et al. Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum. Antimicrob. Agents Chemother. 56(6), 2976\u20132986 (2012).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80017-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80017-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80017-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T01:44:31Z","timestamp":1670031871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80017-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80017"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80017-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"10 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"471"}}